Hyaluronidase Via LADD Scleroderma-induced Microstomia
Condition(s):Microstomia; SclerodermaLast Updated:March 8, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Microstomia; SclerodermaLast Updated:March 8, 2024Recruiting
Condition(s):Pain, PostoperativeLast Updated:July 27, 2023Recruiting
Condition(s):Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone LymphomaLast Updated:November 29, 2023Recruiting
Condition(s):Non-Small Cell Lung Cancer; Renal Cell Carcinoma; MelanomaLast Updated:March 15, 2024Recruiting
Condition(s):Castration-Resistant Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8Last Updated:March 12, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:January 8, 2024Recruiting
Condition(s):T-cell Acute Lymphoblastic LeukemiaLast Updated:December 19, 2023Recruiting
Condition(s):Thyroid Eye DiseaseLast Updated:March 20, 2023Recruiting
Condition(s):Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV; Stage III Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Unresectable MelanomaLast Updated:June 28, 2022Recruiting
Condition(s):Multiple Myeloma; Renal FailureLast Updated:December 13, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.